Key Highlights 10 mg lyophilized Retatrutide per vial Also known as Retatrutide, LY3437943, and LY-3437943 Triple GCGR / GIPR / GLP-1R receptor agonist research compound Sealed 3 mL glass vial with batch-labeled traceability Janoshik Laboratory source-lab documentation Independent Testide Canada Laboratory verification arranged by Precision Synthetics Canada LAL endotoxin screening through Testide for added batch-quality review COA access for supported batches Ships from Vancouver, Canada LAL Endotoxin Screening + Dual Third-Party Review Purity matters, but it is only one part of responsible batch review
Store in original sealed vials, protected from light
Research on people and animals has shown that gut bacteria undergo major changes after the surgery
Volume = 1 mg / 5 mg/ml = 0.2 ml Challenge here: 0.2 ml is very difficult to measure with a standard syringe
Ernie Blevins, an endocrinologist at the University of Washington, and his colleagues co-administered oxytocin and a low dose of tirzepatide, a dual agonist mimicking the effects of both GLP-1 and glucose-dependent insulinotropic polypeptide, to obese rats and discovered that together, they produced more pronounced weight loss than either treatment alone
It may also be assigned a tier number
